Communicable Disease Center, Tan Tock Seng Hospital, Singapore, Singapore.
PLoS One. 2013;8(4):e60946. doi: 10.1371/journal.pone.0060946. Epub 2013 Apr 1.
Revised dengue guidelines were published by the World Health Organization (WHO) in 2009 addressing severe dengue cases not classified by dengue hemorrhagic fever (DHF) and shock syndrome (DSS).
We conducted a retrospective cohort study to compare WHO 2009 and 1997 classifications using 1278 adult dengue cases confirmed by polymerase chain reaction assay from Singapore epidemics in 2004 and 2007 (predominantly serotype 1 and 2 respectively).DHF occurred in 14.3%, DSS 2.7% and severe dengue 16.0%. The two WHO dengue classifications were discordant in defining severe disease (p<0.001). Five DSS patients (15%) were classified as non-severe dengue without warning signs. Of severe dengue patients, 107 did not fulfil DHF criteria. Of these, 14.9% had self-resolving isolated elevated aminotransferases, 18.7% gastrointestinal bleeding without hemodynamic compromise and 56.1% plasma leakage with isolated tachycardia. We compared both guidelines against requirement for intensive care including the single death in this series: all six had severe dengue; only four had DHF as two lacked bleeding manifestations but had plasma leakage. Increasing length of hospitalization was noted among severe cases with both classifications but the trend was only statistically significant for WHO 2009. Length of hospitalization was significantly longer for severe plasma leakage compared with severe bleeding or organ impairment. Requirement for hospitalization increased using WHO 2009 from 17.0% to 51.3%.
While the WHO 2009 dengue classification is clinically useful, we propose retaining criteria for plasma leakage and hemodynamic compromise from WHO 1997, and refining definitions of severe bleeding and organ impairment to improve clinical relevance having found that differences in these accounted for the discordance between classifications. Findings from our retrospective study may be limited by the study site - a tertiary referral center in a hyperendemic country - and should be evaluated in a wider range of geographic settings.
世界卫生组织(WHO)于 2009 年发布了修订后的登革热指南,针对未被登革出血热(DHF)和休克综合征(DSS)分类的重症登革热病例。
我们进行了一项回顾性队列研究,比较了 2004 年和 2007 年新加坡流行期间通过聚合酶链反应检测证实的 1278 例成人登革热病例,分别为血清型 1 和 2 (占主导地位),使用 2009 年和 1997 年的 WHO 分类。DHF 发生率为 14.3%,DSS 为 2.7%,重症登革热为 16.0%。两种 WHO 登革热分类在定义重症疾病方面存在差异(p<0.001)。5 例 DSS 患者(15%)无预警信号被归类为非重症登革热。在重症登革热患者中,有 107 例不符合 DHF 标准。其中,14.9%的患者有自行缓解的孤立性氨基转移酶升高,18.7%的患者有胃肠道出血但无血流动力学障碍,56.1%的患者有血浆渗漏但仅有心动过速。我们比较了这两种指南与需要重症监护的要求,包括该系列中唯一的死亡病例:所有 6 例均为重症登革热;仅有 4 例符合 DHF,因为其中 2 例缺乏出血表现,但有血浆渗漏。两种分类均显示重症病例的住院时间延长,但只有 2009 年 WHO 分类的趋势具有统计学意义。与重症出血或器官损伤相比,重症血浆渗漏的住院时间明显更长。使用 2009 年 WHO 标准,住院需求从 17.0%增加到 51.3%。
虽然 2009 年 WHO 登革热分类在临床上是有用的,但我们建议保留 1997 年 WHO 的血浆渗漏和血流动力学障碍标准,并改进严重出血和器官损伤的定义,以提高临床相关性,因为我们发现这些标准的差异导致了分类之间的不一致。我们的回顾性研究结果可能受到研究地点的限制-在一个高度流行的国家的三级转诊中心-并且应该在更广泛的地理环境中进行评估。